Evidence map›Paper›PMID 32610693›Full record

ArticleInternational journal of molecular sciences2020

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?

Sylwia Szpak-Ulczok, Aleksandra Pfeifer, Dagmara Rusinek, Malgorzata Oczko-Wojciechowska, Malgorzata Kowalska, Tomasz Tyszkiewicz, Marta Cieslicka, Daria Handkiewicz-Junak, Krzysztof Fujarewicz, Dariusz Lange and 9 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Cell and Molecular Biology of Thyroid Disorders 2.0.International journal of molecular sciences · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 3 countries.

Sylwia Szpak-UlczokNuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Aleksandra PfeiferDepartment of Genetic and Molecular Diagnostics of Cancer, Maria Sklodowska, Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.ORCID 0000-0002-0189-9711
Dagmara RusinekDepartment of Genetic and Molecular Diagnostics of Cancer, Maria Sklodowska, Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Malgorzata Oczko-WojciechowskaDepartment of Genetic and Molecular Diagnostics of Cancer, Maria Sklodowska, Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.ORCID 0000-0002-8989-0075
Malgorzata KowalskaDepartment of Genetic and Molecular Diagnostics of Cancer, Maria Sklodowska, Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Tomasz TyszkiewiczDepartment of Genetic and Molecular Diagnostics of Cancer, Maria Sklodowska, Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Marta CieslickaDepartment of Genetic and Molecular Diagnostics of Cancer, Maria Sklodowska, Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Daria Handkiewicz-JunakNuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Krzysztof FujarewiczInstitute of Automatic Control, Silesian University of Technology, 44-100 Gliwice, Poland.
Dariusz LangeTumor Pathology Department, Maria Sklodowska, Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Ewa ChmielikTumor Pathology Department, Maria Sklodowska, Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Ewa Zembala-NozynskaTumor Pathology Department, Maria Sklodowska, Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Sebastian StudentInstitute of Automatic Control, Silesian University of Technology, 44-100 Gliwice, Poland.
Agnieszka Kotecka-BlicharzNuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Aneta Kluczewska-GalkaNuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Barbara JarzabNuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Agnieszka CzarnieckaThe Oncologic and Reconstructive Surgery Clinic, Maria Sklodowska, Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.ORCID 0000-0003-1249-7205
Michal JarzabBreast Unit, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.ORCID 0000-0002-2642-9724
Jolanta KrajewskaNuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
The Maria Sklodowska-Curie National Research Institute of Oncology · PLSilesian University of Technology · PLBreast Center · CH

Funding

Polish National Center of Research and Development MILESTONE project - Molecular diagnostics and imaging in individualized therapy for breast, thyroid and prostate cancer STRATEGMED 2/267398/4/NCBR/2015
6 · The paper itself

Abstract

Molecular mechanisms of distant metastases (M1) in papillary thyroid cancer (PTC) are poorly understood. We attempted to analyze the gene expression profile in PTC primary tumors to seek the genes associated with M1 status and characterize their molecular function. One hundred and twenty-three patients, including 36 M1 cases, were subjected to transcriptome oligonucleotide microarray analyses: (set A-U133, set B-HG 1.0 ST) at transcript and gene group level (limma, gene set enrichment analysis (GSEA)). An additional independent set of 63 PTCs, including 9 M1 cases, was used to validate results by qPCR. The analysis on dataset A detected eleven transcripts showing significant differences in expression between metastatic and non-metastatic PTC. These genes were validated on microarray dataset B. The differential expression was positively confirmed for only two genes:

Indexed as

AdolescentAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, PapillaryChildChild, PreschoolExtracellular Matrix ProteinsFemaleGene ExpressionGene Expression ProfilingHumansMaleMiddle AgedNeoplasm MetastasisBiomarkers, TumorExtracellular Matrix Proteinsdistant metastasesgene expression profilemicroarraypapillary thyroid cancer

Identifiers

PMID32610693
PMCPMC7369779
OpenAlexW3037755131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.